Jennison Associates LLC Incyte Corp Transaction History

Jennison Associates LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 06, 2019	SELL	$58.5 - $69.94 $34.4 Million - $41.1 Million	-587,696 Closed	0 $0
Q3 2018 Nov 08, 2018	SELL	$61.75 - $74.23 $3.55 Million - $4.27 Million	-57,487 Reduced 8.91%	587,696 $40.6 Million
Q2 2018 Aug 02, 2018	SELL	$60.85 - $83.98 $18.2 Million - $25.1 Million	-299,237 Reduced 31.68%	645,183 $43.2 Million
Q1 2018 Apr 20, 2018	BUY	$83.06 - $100.98 $9.42 Million - $11.5 Million	113,472 Added 13.66%	944,420 $78.7 Million
Q4 2017 Jan 25, 2018	SELL	$93.56 - $116.6 $75.1 Million - $93.5 Million	-802,225 Reduced 49.12%	830,948 $78.7 Million
Q3 2017 Nov 03, 2017	BUY	$109.15 - $138.27 $178 Million - $226 Million	1,633,173	1,633,173 $191 Million

645

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.3B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Jennison Associates LLC with notifications on news.